Yellow Fever Emergence: Role of Heterologous Flavivirus Immunity in Preventing Urban Transmission
Divya P. ShindeiD, Jessica A. PlanteiD, Dionna SchartoniD, Brooke M. MitchelliD, Jordyn L. Walker, Sasha R. AzariD, Rafael Kroon CamposiD, Lívia SacchettoiD, Betânia Paiva DrumondiD, Nikos VasilakisiD, Kenneth S. PlanteiD, Scott C. WeaveriD
Abstract
During major, recent yellow fever (YF) epidemics in Brazil, human cases were attributed only to spillover infections from sylvatic transmission with no evidence of human amplification. Furthermore, the historic absence of YF in Asia, despite abundant peridomestic Aedes aegypti and naive human populations, represents a longstanding enigma. We tested the hypothesis that immunity from dengue (DENV) and Zika (ZIKV) flaviviruses limits YF virus (YFV) viremia and transmission by Ae. aegypti. Prior DENV and ZIKV immunity consistently suppressed YFV viremia in experimentally infected macaques, leading to reductions in Ae. aegypti infection when mosquitoes were fed on infected animals. These results indicate that, in DENV- and ZIKV-endemic regions such as South America and Asia, flavivirus immunity suppresses YFV human amplification potential, reducing the risk of urban outbreaks. One-Sentence SummaryImmunity from dengue and Zika viruses suppresses yellow fever viremia, preventing infection of mosquitoes and reducing the risk of epidemics.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 14
- FWCI
- 4.72
- Field percentile
- top 5%
- Organism
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Prior flavivirus immunity skews the yellow fever vaccine response to expand cross-reactive antibodies with increased risk of antibody dependent enhancement of Zika and dengue virus infection
A. Santos-Peral, F. Luppa, … S. Rothenfusser·bioRxiv·May 7, 2023
- Midgut barriers prevent the replication and dissemination of the yellow fever vaccine in Aedes aegypti
L. Danet, G. Beauclair, … n. jouvenet·bioRxiv·Mar 13, 2019
- Pre-existing YFV-17D immunity mediates T cell cross-protection against DENV-2 infection
Prince Baffour Tonto, Sebastian Gallon, … Bobby Brooke Herrera·bioRxiv·Apr 16, 2025
- Yellow Fever Vaccine Protects Resistant and Susceptible Mice Against Zika Virus Infection
A. C. Vicente Santos, F. H. Guedes-da-Silva, … J. L. Silva·bioRxiv·Mar 29, 2019
- Heterologous flavivirus exposure provides varying degrees of cross-protection from Zika virus in a mouse model of infection
M. A. Hassert, S. Scroggins, … A. K. Pinto·bioRxiv·Dec 23, 2020
- Reemergence of yellow fever virus in southeastern Brazil, 2017-2018: what sparked the spread?
J. I. Rosser, K. Nielsen-Saines, … T. Fuller·bioRxiv·Sep 2, 2021